EN CN
EN CN

PIPELINE

ONCOLOGY

(Nerlynx ®)

CAN030

MORE

INDICATION

Extended adjuvant for Her2 breast cancer

Metastatic Her2 breast cancer

Gastric Cancer

DEVELOPMENT STATUS

MAA

Phase III

IND

(MAH Pilot Project)

CAN008

MORE

INDICATION

Glioblastoma multiforme

DEVELOPMENT STATUS

Phase II/III

Taiwan Phase 1

CAN017

MORE

INDICATION

Squamous cell esophageal cancer

DEVELOPMENT STATUS

Phase I/III

CAN002

MORE

INDICATION

Mucositis caused by radiation or high dose chemotherapy

DEVELOPMENT STATUS

MAA

RARE DISEASE

CANbridge launched rare disease business platform to commercialize Western rare disease therapies via an innovative business approach in China.

Focused therapeutic areas

  • Chronic diseases with official rare disease designations.

  • Serious & debilitating diseases excluding cancers.

  • Genetic diseases with unique genetic profile/prevalence in China.

  • Significant unmet medical needs in China.

MORE